Department of Public Health, Kyoto Pharmaceutical University.
Faculty of Pharmaceutical Sciences, Nagasaki International University.
Chem Pharm Bull (Tokyo). 2023;71(7):495-501. doi: 10.1248/cpb.c21-00832.
We isolated the new sesquiterpenes, valerianaterpenes IV and V, and the new lignans valerianalignans I-III from the methanol extracts of the rhizomes and roots of Valeriana fauriei and elucidated their structures based on chemical and spectroscopic findings. The absolute configuration of valerianaterpene IV and valerianalignans I-III were established by comparing experimental and predicted electronic circular dichroism (ECD) data. Among the isolated compounds, valerianalignans I and II exerted anti-proliferative activity against human astrocytoma cells (U-251 MG) and their cancer stem cells (U-251 MG CSCs). Interestingly, valerianalignans I and II notably exerted anti-proliferative activities at lower concentrations against CSCs than non-CSCs, and the absolute configurations of these compounds affected their activities.
我们从缬草属植物的甲醇提取物中分离出新的倍半萜类化合物缬草萜烯 IV 和 V,以及新的木质素缬草木质素 I-III,并根据化学和光谱发现阐明了它们的结构。通过比较实验和预测的电子圆二色性 (ECD) 数据,确定了缬草萜烯 IV 和缬草木质素 I-III 的绝对构型。在所分离的化合物中,缬草木质素 I 和 II 对人星形细胞瘤细胞 (U-251 MG) 和其癌细胞干细胞 (U-251 MG CSCs) 表现出抗增殖活性。有趣的是,缬草木质素 I 和 II 对 CSCs 的抗增殖活性在较低浓度下明显高于非 CSCs,并且这些化合物的绝对构型影响其活性。